Suggestions
Jessica Vitos, PhD
Biotech Investor
Jessica Vitos, Ph.D. is a Senior Manager of Innovation at Grifols and a biotech investor with a strong scientific background, particularly in oncology.3 Here are some key details about her:
Professional Background
Current Role::
- Senior Manager at Grifols' corporate venture arm, called Grifols Innovation and New Technologies (GIANT)45
- Board Member of YVC Collective1
Expertise::
- Biotech investing
- Drug development
- Innovation in healthcare
Education and Skills
Jessica Vitos holds a Ph.D., indicating an advanced degree in a scientific field, likely related to her expertise in oncology and biotechnology.3
Professional Activities
- She participates in industry events and conferences, such as Bio€quity Europe 2024, where she was listed as a faculty member1
- Vitos has been involved in panel discussions and round tables, sharing her expertise on drug development and career paths in the biotech industry2
- She is active in promoting Grifols' commitment to developing future therapies and expanding their innovative reach4
Career Focus
Jessica Vitos works at the intersection of science and business, leveraging her scientific background to make informed investment decisions in the biotech sector. Her role at Grifols involves identifying and supporting innovative technologies and therapies that align with the company's goals of treating more patients.45
Highlights
May 8 · media.biocentury.com
[PDF] bio€quity presenting company class of 2024
Nov 17 · catalonia.health
Immunotherapies using antibody engineering: new targets ...
Jan 29 · Drug Target Review
Study shows that lung tumour growth can be reduced by inhibiting p38 - Drug Target Review
Jan 23 · EurekAlert
Inhibition of p38 reduces the growth of lung tumors - EurekAlert